Northern Trust Corp Has $18.25 Million Stock Holdings in Sotera Health (NASDAQ:SHC)

Northern Trust Corp raised its position in Sotera Health (NASDAQ:SHC) by 23.6% during the 4th quarter, HoldingsChannel reports. The fund owned 1,334,367 shares of the company’s stock after buying an additional 254,768 shares during the quarter. Northern Trust Corp’s holdings in Sotera Health were worth $18,254,000 as of its most recent SEC filing.

Other large investors have also recently bought and sold shares of the company. Xponance Inc. raised its holdings in shares of Sotera Health by 6.0% in the fourth quarter. Xponance Inc. now owns 17,495 shares of the company’s stock valued at $239,000 after purchasing an additional 989 shares during the last quarter. Wealth Enhancement Advisory Services LLC boosted its holdings in Sotera Health by 2.1% during the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 51,940 shares of the company’s stock worth $711,000 after purchasing an additional 1,047 shares during the last quarter. Blue Trust Inc. increased its stake in Sotera Health by 164.3% in the 4th quarter. Blue Trust Inc. now owns 1,834 shares of the company’s stock valued at $25,000 after buying an additional 1,140 shares during the last quarter. Tower Research Capital LLC TRC increased its stake in Sotera Health by 37.8% in the 4th quarter. Tower Research Capital LLC TRC now owns 5,975 shares of the company’s stock valued at $82,000 after buying an additional 1,640 shares during the last quarter. Finally, Bank of Montreal Can lifted its position in Sotera Health by 10.6% during the 4th quarter. Bank of Montreal Can now owns 18,184 shares of the company’s stock worth $249,000 after buying an additional 1,740 shares in the last quarter. Institutional investors and hedge funds own 91.03% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts have recently commented on the stock. The Goldman Sachs Group upgraded shares of Sotera Health from a “neutral” rating to a “buy” rating and increased their price objective for the stock from $14.00 to $17.00 in a research note on Monday, May 5th. Barclays reduced their price target on Sotera Health from $16.00 to $12.00 and set an “overweight” rating for the company in a research report on Thursday, April 10th. Finally, Piper Sandler lowered their price target on Sotera Health from $15.00 to $13.00 and set a “neutral” rating on the stock in a research report on Wednesday, April 23rd. One investment analyst has rated the stock with a hold rating and four have given a buy rating to the company. Based on data from MarketBeat.com, Sotera Health has an average rating of “Moderate Buy” and an average target price of $15.80.

Sotera Health Stock Performance

Shares of SHC stock opened at $13.24 on Wednesday. The company has a fifty day moving average price of $11.51 and a two-hundred day moving average price of $12.91. Sotera Health has a one year low of $9.53 and a one year high of $17.08. The stock has a market cap of $3.76 billion, a P/E ratio of 52.96 and a beta of 1.88. The company has a debt-to-equity ratio of 4.91, a current ratio of 2.88 and a quick ratio of 2.61.

Sotera Health (NASDAQ:SHC) last issued its earnings results on Thursday, May 1st. The company reported $0.14 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.12 by $0.02. Sotera Health had a net margin of 6.31% and a return on equity of 42.27%. The business had revenue of $254.52 million during the quarter, compared to the consensus estimate of $245.56 million. During the same period last year, the business posted $0.13 EPS. Sotera Health’s revenue was up 2.6% on a year-over-year basis. As a group, equities analysts predict that Sotera Health will post 0.61 EPS for the current year.

Sotera Health Company Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.